Advances and updates in sexual health for 2019 – Dr. Suneeta Soni Welcome to your Advances and updates in sexual health for 2019 - Dr. Suneeta Soni Cefriaxone resistance in the UK in 2019 is about 2%? a. True b. False Ciprofloxacin resistance in the UK in 2019 is about 39%? a. True b. False Which of the following statements about gonorrhoea are true? Tick all that apply a. Gonorrhoea usually causes symptoms in the male urethra b. For patients with pharyngeal gonorrhoea, gentamicin is a suitable alternative to ceftriaxone in the case of severe penicillin allergy c. Patients receiving treatment for gonorrhoea should be given azithromycin to cover co-infection with chlamydia where the chlamydia status is unknown d. Patients being treated with anything other than ceftriaxone should have a test of cure to confirm eradication of organism e. All partners of patients with gonorrhoea should be offered empirical treatment The current first line treatment for Mycoplasma genitalium urethritis is:- a. Azithromycin b. Doxycycline c. Doxycycline followed by azithromycin d. Doxycycline followed by moxifloxacin e. Moxifloxacin The prevalence of mycoplasma genitalium in women with PID is similar to that of chlamydia? a. True b. False The best way to diagnose Mycoplasma genitalium is by culture of organism? a. True b. False Which of the following statements about partners of patients with Mgen are true? a. All partners should be tested for Mgen and treated if positive? b. A look-back period of 6 months is reasonable to capture all relevant partners? c. Partners should only be offered treatment if they are symptomatic? d. Treatment of partners should be with the same antibiotic regimen as that of the index patient? Which of the following drugs are safe to prescribe in pregnant women with Mycoplasma genitalium? a. Azithromycin b. Moxifloxacin c. Doxycycline d. Pristinamycin e. Minacycline Time's up
Leave a Reply
You must be logged in to post a comment.